Company Directory > MedTech > TINGSN (Jiangsu Tingsn Technology Co., Ltd.)
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of TINGSN (Jiangsu Tingsn Technology Co., Ltd.) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Jiangsu Tingsn Technology Co., Ltd. (TINGSN) is a Chinese medical device company focused on the research, development, and production of cardiac electrophysiological interventional devices. The company specializes in intracardiac echocardiography (ICE) technology, aiming to provide localized, cost-effective solutions for cardiac arrhythmia treatments and to compete with international medical device brands. TINGSN's product portfolio includes disposable intracardiac ultrasound diagnostic catheters, portable color ultrasound diagnostic equipment, and systems for 3D cardiac mapping and ultrasound ablation. The company operates R&D and manufacturing facilities in Nanjing and Suzhou, China, and maintains a presence in the United States. It leverages collaborations with academic institutions like Nanjing University and Purdue University to drive innovation in catheter positioning and software algorithms.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Cardiac Electrophysiology / Diagnostic Imaging
SIZE & FINANCIALS
Employees:51-200
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Series B+
Investors:Qiming Venture Partners, Huatai Zijin, Tasly Capital, Ascendum Capital, Nanwan Baiao Fund, Hunan Chasing Fund Management, Jinshan Capital, Ti Capital Management, Nuoyu Capital, Origins Capital
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Disposable Intracardiac Ultrasound Diagnostic Catheter)
Modalities:Intracardiac Echocardiography (ICE), Ultrasound Imaging, Cardiac Ablation
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Nanjing University (R&D collaboration), Purdue University (R&D collaboration)
COMPETITION
Position:Emerging
Competitors:Johnson & Johnson (Biosense Webster), Abbott, Cardioacc (心寰科技), SonoSemi (赛禾医疗), Intelligent Healthcare (冰晶智能)
LEADERSHIP
Key Executives:
Zhao Dongsheng - Founder/Key Leader
LINKS
Website:tingsn.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with TINGSN (Jiangsu Tingsn Technology Co., Ltd.). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.